Press Releases | Mylan http://newsroom.mylan.com/ MediaRoom Mylan Completes $1 Billion Share Repurchase Plan http://newsroom.mylan.com/press-releases?item=123545 Tue, 09 Jan 2018 17:00:00 -0500 http://newsroom.mylan.com/press-releases?item=123545 Mylan to Complete $1 Billion Share Repurchase Plan http://newsroom.mylan.com/2018-01-08-Mylan-to-Complete-1-Billion-Share-Repurchase-Plan Abbott sells remaining 20.3 million shares of Mylan Mon, 08 Jan 2018 07:30:00 -0500 http://newsroom.mylan.com/2018-01-08-Mylan-to-Complete-1-Billion-Share-Repurchase-Plan Momenta and Mylan Announce Development Strategy for M710, a Proposed Biosimilar to EYLEA® (aflibercept) http://newsroom.mylan.com/2018-01-03-Momenta-and-Mylan-Announce-Development-Strategy-for-M710-a-Proposed-Biosimilar-to-EYLEA-R-aflibercept -- Targeting the initiation of a pivotal patient clinical trial in the first half of 2018 -- Wed, 03 Jan 2018 16:05:00 -0500 http://newsroom.mylan.com/2018-01-03-Momenta-and-Mylan-Announce-Development-Strategy-for-M710-a-Proposed-Biosimilar-to-EYLEA-R-aflibercept Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream http://newsroom.mylan.com/2017-12-29-Mylan-Adds-to-U-S-Womens-Healthcare-Portfolio-With-FDA-Approval-of-First-Generic-for-Estrace-R-Cream Mylan now offers estradiol in four delivery methods Fri, 29 Dec 2017 10:47:00 -0500 http://newsroom.mylan.com/2017-12-29-Mylan-Adds-to-U-S-Womens-Healthcare-Portfolio-With-FDA-Approval-of-First-Generic-for-Estrace-R-Cream Biocon and Mylan's Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through their Partner Libbs http://newsroom.mylan.com/2017-12-29-Biocon-and-Mylans-Biosimilar-Trastuzumab-Receives-Approval-from-ANVISA-Brazil-Through-their-Partner-Libbs Fri, 29 Dec 2017 01:30:00 -0500 http://newsroom.mylan.com/2017-12-29-Biocon-and-Mylans-Biosimilar-Trastuzumab-Receives-Approval-from-ANVISA-Brazil-Through-their-Partner-Libbs